Hepatocyte growth factor: a regenerative drug for acute hepatitis and liver cirrhosis

S Mizuno, T Nakamura - 2007 - Future Medicine
Liver cirrhosis is a major cause of morbidity worldwide and is characterized by the loss of
hepatocytes with interstitial fibrosis. In this review, we discuss the potential uses of …

Hepatocyte growth factor: a regenerative drug for acute hepatitis and liver cirrhosis.

S Mizuno, T Nakamura - Regenerative Medicine, 2007 - europepmc.org
Liver cirrhosis is a major cause of morbidity worldwide and is characterized by the loss of
hepatocytes with interstitial fibrosis. In this review, we discuss the potential uses of …

Hepatocyte growth factor: a regenerative drug for acute hepatitis and liver cirrhosis

S Mizuno, T Nakamura - Regenerative Medicine, 2007 - cir.nii.ac.jp
抄録< jats: p> Liver cirrhosis is a major cause of morbidity worldwide and is characterized by
the loss of hepatocytes with interstitial fibrosis. In this review, we discuss the potential uses …

Hepatocyte Growth Factor: A Regenerative Drug for Acute Hepatitis and Liver Cirrhosis

S Mizuno, T Nakamura - Regenerative Medicine, 2007 - Taylor & Francis
Liver cirrhosis is a major cause of morbidity worldwide and is characterized by the loss of
hepatocytes with interstitial fibrosis. In this review, we discuss the potential uses of …

Hepatocyte growth factor: a regenerative drug for acute hepatitis and liver cirrhosis

S Mizuno, T Nakamura - Regenerative medicine, 2007 - pubmed.ncbi.nlm.nih.gov
Liver cirrhosis is a major cause of morbidity worldwide and is characterized by the loss of
hepatocytes with interstitial fibrosis. In this review, we discuss the potential uses of …

Hepatocyte growth factor: a regenerative drug for acute hepatitis and liver cirrhosis

S Mizuno, T Nakamura - Regenerative Medicine, 2007 - search.proquest.com
Liver cirrhosis is a major cause of morbidity worldwide and is characterized by the loss of
hepatocytes with interstitial fibrosis. In this review, we discuss the potential uses of …